EFEMORAL MEDICAL, INC.
LOS ALTOS, CA · Founded 2015 · CIK 0001758320 · Medtech · Private
Balloon-expandable, resorbable, drug-eluting scaffold for treating femoropopliteal arterial occlusion
efemoralmedical.com →- Grants
- $4.3M
- 5 awards
- Sector median: 1
- Raised
- $4.7M
- 3 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 20
- 5 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,010,000 | |
| Federal grant | Department of Health and Human Services · Phase I · PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF SERIAL, BALLOON-EXPANDABLE, PACLITAXEL-ELUTING RESORBABLE SCAFFOLDS (the Efemoral Device) | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF SERIAL, BALLOON-EXPANDABLE, PACLITAXEL-ELUTING RESORBABLE SCAFFOLDS (the Efemoral Device) | $150,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System) | $783,064 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System) | $1,976,052 | |
| Private capital raised | Form D · SEC | $3,190,000 | |
| Private capital raised | Form D · SEC | $525,000 | |
| Federal grant | Department of Health and Human Services · Phase II · PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System) | $1,192,988 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1220 | MICROTRANSPONDER, INC. | — | $108M |
| 1221 | TF Instruments | — | — |
| 1222 | Fresenius Medical Care Cedar Hill, LLC | — | $928K |
| 1223 | EFEMORAL MEDICAL, INC. | — | $4.7M |
| 1224 | Happy Fireflies Ltd Liability Co | — | $2.0M |
| 1225 | VINE MEDICAL, INC. | — | $50K |
| 1226 | MATERIALIZE BIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher HaigDirector · Executive Officer
Patents
- Absorbable Intravascular Devices That Shorten Upon Expansion Creating Space For Vascular Movementgranted
- Absorbable Intravascular Devices That Exhibit Their Greatest Radial Strength At Their Nominal Diametersgranted
- Temporary Intravascular Scaffolds For The Treatment Of Residual Stenosis Following Balloon Angioplastyapplication
- Absorbable Intravascular Stents Having A Therapeutic Drug Within The Scaffoldapplication
- Absorbable Intravascular Devices That Provide A Decrease In Radial Rigidity Of The Vessel Over Timegranted
- Segmented Balloon-expandable Stent System For Preservation Of The Arterial Lumen During Bendingapplication
- Radially Rigid And Longitudinally Flexible Multi-element Intravascular Stentapplication
- Absorbable Intravascular Devices For The Treatment Of Venous Occlusive Diseaseapplication
- Absorbable Intravascular Devices That Shorten Upon Expansion Creating Space For Vascular Movementgranted
- Multi-element Bioresorbable Intravascular Stentgranted
- Absorbable Intravascular Devices For The Treatment Of Venous Occlusive Diseaseapplication
- Biocopolymer Backbones For Intravascular Scaffoldsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.